Skip to main content

Abivax SA (ABVX)

NASDAQ: ABVX · IEX Real-Time Price · USD
10.70
-0.10 (-0.93%)
Dec 29, 2023, 4:30 PM EST - Market closed

Abivax Market Cap

Abivax has a market cap or net worth of $673.22 million as of December 29, 2023.

Market Cap
673.22M
Enterprise Value
609.24M
1-Year Change
n/a
Ranking
#2771
Category
Small-Cap
Stock Price
$10.70

Market Cap Chart

Since October 20, 2023, Abivax's market cap has increased from $521.80M to $673.22M, an increase of 29.02%. That is a compound annual growth rate of 277.54%.

History

DateMarket Cap% Change
Dec 29, 2023672.70M
-0.93%
Dec 28, 2023679.00M
0.09%
Dec 27, 2023678.40M
-0.37%
Dec 26, 2023680.90M
-3.99%
Dec 22, 2023709.20M
4.34%
Dec 21, 2023679.70M
2.27%
Dec 20, 2023664.60M
-7.28%
Dec 19, 2023716.80M
8.26%
Dec 18, 2023662.10M
0.29%
Dec 15, 2023660.20M
0.49%
Dec 14, 2023657.00M
0.38%
Dec 13, 2023654.50M
0.18%
Dec 12, 2023653.30M
-0.27%
Dec 11, 2023655.10M
-0.67%
Dec 8, 2023659.50M
1.84%
Dec 7, 2023647.60M
0.89%
Dec 6, 2023641.90M
0.39%
Dec 5, 2023639.40M
-0.98%
Dec 4, 2023645.70M
1.99%
Dec 1, 2023633.10M
-0.80%
Nov 30, 2023638.20M
1.51%
Nov 29, 2023628.70M
2.03%
Nov 28, 2023616.20M
-1.69%
Nov 27, 2023626.80M
-3.21%
Nov 24, 2023647.60M
1.78%
View and export this data all the way back to 2023. Start Free Trial.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Edgewise Therapeutics 713.63M
Adaptive Biotechnologies 710.11M
Fusion Pharmaceuticals 700.16M
Vera Therapeutics 686.04M
Travere Therapeutics 679.69M
Tarsus Pharmaceuticals 674.67M
Avidity Biosciences 674.32M
Alector 670.99M
Market Cap Rankings